Valuation: Windlas Biotech Limited

Market Cap 20.52B 218M 196M 179M 163M 308M 317M 2.16B 860M 10.95B 819M 802M 34.57B P/E 2025
36x
P/E 2026 23.7x
Enterprise Value 18.08B 192M 173M 158M 144M 271M 280M 1.9B 758M 9.65B 722M 707M 30.46B EV / Sales 2025
2.59x
EV / Sales 2026 1.45x
Free-Float
33.78%
Yield 2025
0.56%
Yield 2026 0.86%
1 day+2.41%
1 week+11.96%
Current month+16.24%
1 month+2.70%
3 months+21.29%
6 months+23.77%
Current year+28.09%
1 week 861
Extreme 861
1,059.8
1 month 858
Extreme 858
1,059.8
Current year 697.4
Extreme 697.4
1,181.9
1 year 697.4
Extreme 697.4
1,181.9
3 years 377.05
Extreme 377.05
1,198.25
5 years 203.25
Extreme 203.25
1,198.25
10 years 203.25
Extreme 203.25
1,198.25
Manager TitleAgeSince
Chief Executive Officer - 2023-02-07
Corporate Officer/Principal 48 2025-04-29
Compliance Officer - 2021-05-05
Director TitleAgeSince
Director/Board Member 76 2000-12-31
Director/Board Member 48 2006-03-31
Director/Board Member 49 2008-01-20
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%+11.96%+19.76%+166.32% 218M
-0.79%-4.48%+46.48%+125.69% 1,206B
+1.43%+1.11%+48.05%+83.05% 665B
+1.07%-1.21%+32.92%+104.92% 515B
-0.36%-3.25%+45.42%+65.10% 381B
-0.14%-1.87%+70.06%+41.09% 362B
-0.78%-0.52%+30.47%+58.09% 307B
-0.80%-0.21%+7.98%+36.17% 289B
+0.03%-1.20%+43.79%+69.83% 249B
-0.41%-2.22%+40.43%+107.03% 207B
Average +0.17%-0.04%+38.54%+85.73% 418B
Weighted average by Cap. -0.04%-1.96%+42.71%+88.12%

Financials

2025 2026
Net sales 7.6B 80.84M 72.5M 66.26M 60.49M 114M 118M 799M 318M 4.05B 303M 297M 12.8B 9.04B 96.18M 86.26M 78.84M 71.96M 136M 140M 950M 379M 4.82B 361M 353M 15.23B
Net income 610M 6.49M 5.82M 5.32M 4.86M 9.15M 9.44M 64.11M 25.56M 325M 24.35M 23.83M 1.03B 665M 7.07M 6.34M 5.79M 5.29M 9.97M 10.28M 69.85M 27.85M 355M 26.54M 25.97M 1.12B
Net Debt -2.07B -21.99M -19.72M -18.02M -16.45M -31M -31.97M -217M -86.62M -1.1B -82.53M -80.76M -3.48B -2.44B -25.91M -23.24M -21.24M -19.39M -36.53M -37.68M -256M -102M -1.3B -97.26M -95.17M -4.1B
Projected Income Statement - Annual - Windlas Biotech Limited
Logo Windlas Biotech Limited
Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufacturing capabilities in complex generic products by developing products, including alternate dosages, such as, medicated mouth sprays; coating technologies, including, pellet coating using bottom spray, API coating, pH dependent coating and nanosized crystals; nutraceuticals dosages, including, biscuits, protein powder, supplements, chocolate bars and malt based foods, and ayurvedic products, such as wellness products, hair oils and cough syrups. Its four fungible, Schedule-M compliant OSD/OLD manufacturing facilities are located in Dehradun, Uttarakhand, India. It specializes in manufacturing formulations, solid pharmaceutical dosage forms, liquid pharmaceutical dosage forms and injectables.
Employees
1,385
Date Price Change Volume
26-11-08 ₹1,018.40 +2.41% 40,087
26-11-06 ₹994.40 +7.94% 1,826,194
26-11-05 ₹921.25 +5.47% 184,539
26-11-04 ₹873.45 -0.70% 40,718
26-11-03 ₹879.60 -3.30% 33,604
  1. Stock Market
  2. Stocks
  3. WINDLAS Stock